Progress Article abstract
Nature Nanotechnology 4, 627 - 633 (2009)
Published online: 27 September 2009 | doi:10.1038/nnano.2009.241
Subject Category: Nanomedicine
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics
K. Kostarelos1, A. Bianco2 & M. Prato3
Abstract
The use of carbon nanotubes in medicine is now at the crossroads between a proof-of-principle concept and an established preclinical candidate for a variety of therapeutic and diagnostic applications. Progress towards clinical trials will depend on the outcomes of efficacy and toxicology studies, which will provide the necessary risk-to-benefit assessments for carbon-nanotube-based materials. Here we focus on carbon nanotubes that have been studied in preclinical animal models, and draw attention to the promises, facts and challenges of these materials as they transition from research to the clinical phase. We address common questions regarding the use of carbon nanotubes in disease imaging and therapy, and highlight the opportunities and challenges ahead.
- Nanomedicine Laboratory, Centre for Drug Delivery Research, The School of Pharmacy, University of London, London WC1N 1AX, UK
- CNRS, Immunologie et Chimie Thérapeutiques, Institut de Biologie Moléculaire et Cellulaire UPR9021, 67084 Strasbourg, France
- Dipartimento di Scienze Farmaceutiche,Università di Trieste, 34127 Trieste, Italy.
Correspondence to: K. Kostarelos1 e-mail: kostas.kostarelos@pharmacy.ac.uk
Correspondence to: A. Bianco2 e-mail: a.bianco@ibmc.u-strasbg.fr
Correspondence to: M. Prato3 e-mail: prato@units.it
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Nanomedicine Nanotechnology tackles tumoursNature Nanotechnology News and Views (01 Jan 2007)
Molecular Nanostructures Carbon aheadNature Materials News and Views (01 May 2007)
See all 13 matches for News And Views
